G L Dike. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » 1-Naphthylamine/adverse effects1-Naphthylamine/analogs & derivativesAgedAmantadine/adverse effectsAmantadine/therapeutic useAntiparkinson Agents/therapeutic useBrain Diseases/chemically inducedBrain Diseases/diagnosisCarbidopa/therapeutic useDrug CombinationsDrug Therapy, CombinationElectroencephalographyHallucinations/chemically inducedHumansLevodopa/therapeutic useMaleMyoclonus/chemically inducedParkinson Disease/drug therapySerotonin Uptake Inhibitors/adverse effectsSertralineSyndrome
Substances: See more » Antiparkinson AgentsDrug CombinationsSerotonin Uptake Inhibitorscarbidopa, levodopa drug combinationLevodopa1-NaphthylamineAmantadineCarbidopaSertraline
Year: 1997 PMID: 9048728 PMCID: PMC486739 DOI: 10.1136/jnnp.62.2.200
Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN: 0022-3050 Impact factor: 10.154